Stock Earnings A company insider recently bought 7,415 shares of Immuneering Corp [IMRX]. Should You Buy? Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Analysts Viewpoint Immuneering Corp (IMRX) Becoming More Attractive for Investors In a filing, Immuneering Corp revealed its Director Feinberg Peter acquired Company’s shares for reported $63188.0 on Jun 18 ’25.
Insiders Updates Immuneering Corp [NASDAQ: IMRX] Sees Increase in Stock Value Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immuneering Corp